Sun, Cipla and Gland remain top pharma picks in 2022: Nithya Balasubramanian
“FY23 should look largely normal again on a YoY deflation basis. This year, we have seen price deflations hoving around the high single digits – 8-9%. I hope that it will come down to the normal 4-5% level starting FY23,” says Nithya…